Clinical trial
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic…
NCT00160407 · St. Louis University, Other · Completed
Key facts
| NCT number | NCT00160407 |
|---|---|
| Title | Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) |
| Official title | Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) |
| Lead sponsor | St. Louis University, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Fatty Liver, Hepatitis |
| Intervention type | Behavioral, Drug |
| Interventions | Orlistat (Xenical), 1400 kcal diet (30% fat) |
| Enrollment | 50 |
| Start date | Oct 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Nov 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: